The curious case of a woman who can smell Parkinson’s reminds us our noses are our first defense against illness.
A dopamine deficiency is linked to several health conditions, including Parkinson's disease and depression. Learn more about the symptoms.
Reduced levels of a mitochondrial enzyme were previously thought to destroy neurons in Parkinson's disease. The opposite may, in fact, be the case.
A new study shows that impairment in mitochondria may actually protect the brain in Parkinson’s disease.
A new study strongly suggests that the brains of people who have died of Huntington's disease (HD) and Parkinson's disease (PD) show a similar response to a lifetime of neurodegeneration, despite being two very distinct diseases.
My easy like Sunday morning reads: • Three Anonymous Guys Wiped $3 Billion Off South Africa Stocks in Four Days (Bloomberg) • Pfizer, pocketing a big tax cut from Trump, will end investment in Alzheimer’s and Parkinson’s research (Los...Show More Summary
The world’s third largest pharmaceutical company announced it would lay off 300 scientists.
Parkinsonism is a condition that causes some symptoms of Parkinson’s disease alongside those of another disorder. We also look at diagnosis and treatment.
(University of the Basque Country ) Current therapies for Parkinson's disease are mainly of a replacement type and pose problems in the long term, so the challenge is to establish an early diagnosis and develop neuroprotective and neurorestorative therapies that will allow the symptoms of the disease to be slowed down or even reversed. Show More Summary
(Boston University School of Medicine) A new study strongly suggests that the brains of people who have died of Huntington's disease (HD) and Parkinson's disease (PD) show a similar response to a lifetime of neurodegeneration, despite being two very distinct diseases.
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Findings could lead to new treatments and early diagnosis.
Learn about how genetics affects the development of Parkinson's disease, and when to talk to a doctor about family history and genetic testing.
In a move that will cost approximately 300 people their jobs, Pfizer’s $19 million a year CEO Ian Read shut down his company’s research into cures for Alzheimer’s and Parkinson’s Disease. In a statement sent to NPR, Pfizer officialsShow More Summary
With every passing day, it becomes clearer who’s reaping the benefit of the huge tax cut handed over to American corporations by the Republican-dominated Congress in December. Spoiler alert: Not workers or customers, but shareholders, especially the rich ones. (Don’t be fooled by those $1,000 bonuses...
The pharmaceutical giant said it would be abandoning its neuroscience development programs and allocating its spending elsewhere. The move also means the company will lay off some 300 employees.
Pfizer, one of the world's largest drug companies, announced over the weekend that it would stop work on new drugs to fight Alzheimer's disease and Parkinson's disease. The reason? Pfizer believes that research on the two diseases doesn't make sense financially. More »
In this article, learn all about the symptoms, causes, and types of atypical Parkinsonism, as well as what treatments are available.